View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
FRIDAY, Jan. 14 (HealthDay News) -- Long-term adherence to medications following myocardial infarction (MI) in elderly patients is poor, and it is significantly worse among those with kidney dysfunction, according to a study published online Jan. 13 in the Clinical Journal of the American Society of Nephrology.
Tara I. Chang, M.D., from the Stanford University School of Medicine in Palo Alto, Calif., and colleagues examined long-term adherence to medications in a cohort of 2,103 patients older than 65 who were discharged from the hospital after suffering a MI. Patients were treated with one of the recommended medication classes: angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), β-blockers, and statins. Adherence to these medications was measured by the percentage of days covered for 36 months according to pharmacy refills.
The investigators found that long-term adherence to all three medication classes was poor. On average, patients took their medications for 50 to 60 percent of the 36-month study period. Patients who had baseline kidney dysfunction had significantly lower long-term adherence to ACEI/ARB and β-blockers. Long-term adherence to statins did not vary according to the level of kidney function.
"Future strategies should pay special attention to the elderly with kidney dysfunction because this population may be especially vulnerable to poor long-term medication adherence and its adverse consequences," the authors write.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top